Treatment selection for T3/T4a laryngeal cancer: Chemoradiation versus primary surgery

Annals of Otology, Rhinology and Laryngology

Volumn 124, Issue 11, 2015, Pages 845-851

  Timme, David W ^a   Jonnalagadda, Sashikanth ^a   Patel, Raunak ^a   Rao, Krishna ^a   Robbins, K Thomas ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

laryngeal cancer; laryngoesophageal dysfunction free survival; larynx preservation

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE EFFECTIVENESS; DISEASE FREE SURVIVAL; FEEDING APPARATUS; FEMALE; FOLLOW UP; HUMAN; LARYNGECTOMY; LARYNGOESOPHAGEAL DYSFUNCTION FREE SURVIVAL; LARYNX SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; ORGAN PRESERVATION; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RECURRENCE FREE SURVIVAL; RECURRENT DISEASE; SALVAGE THERAPY; T3 LARYNGEAL SQUAMOUS CELL CARCINOMA; T4A LARYNGEAL SQUAMOUS CELL CARCINOMA; TRACHEOSTOMY; TREATMENT OUTCOME; TREATMENT PLANNING; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; HEAD AND NECK NEOPLASMS; LARYNGEAL NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PATIENT SELECTION; PROCEDURES; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; UNITED STATES;

AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; ILLINOIS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM STAGING; PATIENT SELECTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84952332912     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003489415588130     Document Type: Article

References (15)

1. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991; 324: 1685-1690.
2. Lefebvre JL, Rolland F, Tesselaar M, et al. Phase 3 randomized trial on larynx preservation comparing sequential vs. alternating chemotherapy and radiotherapy. J Natl Cancer Inst. 2009; 101: 142-152.
3. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003; 349: 2091-2098.
4. Chen AY, Fedewa S, Zhu J,. Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States, 1985-2007. Arch Otolaryngol Head Neck Surg. 2011; 137: 1017-1024.
5. Maddox PT, Davies L,. Trends in total laryngectomy in the era of organ preservation: a population-based study. Otolaryngol Head Neck Surg. 2012; 147: 85-90.
6. Hoffman HT, Porter K, Karnell LH, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope. 2006; 116 (9 pt 2 suppl 111): 1-13.
7. Megwalu UC, Sikora AG,. Survival outcomes in advanced laryngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014; 140: 855-860.
8. Staton J, Robbins KT, Newman L, Samant S, Sebelik M, Vieira F,. Factors predictive of poor functional outcomes after chemoradiation for advanced laryngeal cancer. Otolaryngol Head Neck Surg. 2002; 127: 43-47.
9. Ang KK,. Larynx preservation clinical trial design: summary of key recommendations of a consensus panel. Oncologist. 2010; 15 (suppl): 25-29.
10. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Head and neck cancers, version 2. 2013. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp#site. Accessed May 8, 2015.
11. Dziegielewski PT, O'Connell DA, Klein M, et al. Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population based analysis of survival. J Otolaryngol Head Neck Surg. 2012; 41 (suppl 1): S56-S64.
12. Karatzanis AD, Psychogio G, Waldfahrer F, et al. Management of locally advanced laryngeal cancer. J Otolaryngol Head Neck Surg. 2014; 43: 4.
13. Busso F, Micciche F, Rigante M, et al. Oncologic outcomes in advanced laryngeal squamous cell carcinomas treated with different modalities in a single institution: a retrospective analysis of 65 cases. Head Neck. 2011; 34: 573-579.
14. Caudell JJ, Carroll WR, Spencer SA, Bonner JA,. Examination of laryngoesophageal dysfunction-free survival as an endpoint in nonsurgical treatment of squamous cell carcinomas of the larynx and hypopharynx. Cancer. 2011; 117: 4447-4451.
15. Wagner MW, Cure JK, Caudell JJ, et al. Prognostic significance of thyroid or cricoid cartilage invasion in laryngeal or hypopharyngeal cancer treated with organ preserving strategies. Radiat Oncol. 2012; 7: 219.